Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease - PubMed (original) (raw)
doi: 10.1002/mds.23838. Epub 2011 Jul 15.
Affiliations
- PMID: 21766334
- DOI: 10.1002/mds.23838
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease
Kathleen M Shannon et al. Mov Disord. 2012 May.
Abstract
The diagnosis of Parkinson's disease rests on motor signs of advanced central dopamine deficiency. There is an urgent need for disease biomarkers. Clinicopathological evidence suggests that α-synuclein aggregation, the pathological signature of Parkinson's disease, can be detected in gastrointestinal tract neurons in Parkinson's disease. We studied whether we could demonstrate α-synuclein pathology in specimens from unprepped flexible sigmoidoscopy of the distal sigmoid colon in early subjects with Parkinson's disease. We also looked for 3-nitrotyrosine, a marker of oxidative stress. Ten subjects with early Parkinson's disease not treated with dopaminergic agents (7 men; median age, 58.5 years; median disease duration, 1.5 years) underwent unprepped flexible sigmoidoscopy with biopsy of the distal sigmoid colon. Immunohistochemistry studies for α-synuclein and 3-nitrotyrosine were performed on biopsy specimens and control specimens from a tissue repository (23 healthy subjects and 23 subjects with inflammatory bowel disease). Nine of 10 Parkinson's disease samples were adequate for study. All showed staining for α-synuclein in nerve fibers in colonic submucosa. No control sample showed this pattern. A few showed light α-synuclein staining in round cells. 3-Nitrotyrosine staining was seen in 87% of Parkinson's disease cases but was not specific for Parkinson's disease. This study suggests a pattern of α-synuclein staining in Parkinson's disease that was distinct from healthy subjects and those with inflammatory bowel disease. The absence of this pattern in subjects with inflammatory bowel disease suggests it is not a sequel of inflammation or oxidative stress. 3-Nitrotyrosine immunostaining was common in all groups studied, suggesting oxidative stress in the colonic submucosa.
Copyright © 2011 Movement Disorder Society.
Comment in
- A colonic biomarker of Parkinson's disease?
Olanow CW. Olanow CW. Mov Disord. 2012 May;27(6):674-6. doi: 10.1002/mds.25067. Mov Disord. 2012. PMID: 22649001 No abstract available.
Similar articles
- Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Shannon KM, et al. Mov Disord. 2012 May;27(6):716-9. doi: 10.1002/mds.25020. Epub 2012 May 1. Mov Disord. 2012. PMID: 22550057 - Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL. Halliday GM, et al. Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336 - Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
Visanji NP, Marras C, Hazrati LN, Liu LW, Lang AE. Visanji NP, et al. Mov Disord. 2014 Apr;29(4):444-50. doi: 10.1002/mds.25789. Epub 2013 Dec 26. Mov Disord. 2014. PMID: 24375496 Review. - Glial reactions in Parkinson's disease.
McGeer PL, McGeer EG. McGeer PL, et al. Mov Disord. 2008 Mar 15;23(4):474-83. doi: 10.1002/mds.21751. Mov Disord. 2008. PMID: 18044695 Review.
Cited by
- Submandibular gland biopsy for the diagnosis of Parkinson disease.
Beach TG, Adler CH, Dugger BN, Serrano G, Hidalgo J, Henry-Watson J, Shill HA, Sue LI, Sabbagh MN, Akiyama H; Arizona Parkinson’s Disease Consortium. Beach TG, et al. J Neuropathol Exp Neurol. 2013 Feb;72(2):130-6. doi: 10.1097/NEN.0b013e3182805c72. J Neuropathol Exp Neurol. 2013. PMID: 23334596 Free PMC article. - Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
Brás IC, Outeiro TF. Brás IC, et al. Cells. 2021 Feb 12;10(2):375. doi: 10.3390/cells10020375. Cells. 2021. PMID: 33673034 Free PMC article. Review. - Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson's Disease.
Doppler K. Doppler K. J Parkinsons Dis. 2021;11(3):937-947. doi: 10.3233/JPD-202489. J Parkinsons Dis. 2021. PMID: 33814464 Free PMC article. Review. - Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.
Han MN, Finkelstein DI, McQuade RM, Diwakarla S. Han MN, et al. J Pers Med. 2022 Jan 21;12(2):144. doi: 10.3390/jpm12020144. J Pers Med. 2022. PMID: 35207632 Free PMC article. Review. - Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism.
Sun X, Xue L, Wang Z, Xie A. Sun X, et al. Front Neurosci. 2022 Jul 6;16:878239. doi: 10.3389/fnins.2022.878239. eCollection 2022. Front Neurosci. 2022. PMID: 35873830 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical